Terns’ oral weight-loss drug has shown promising results in early-stage studies
Terns Pharmaceuticals said its oral obesity drug reduced weight by an average of 4.9 per cent in an early-stage study, joining drugmakers vying for a share of the lucrative weight-loss market, and its shares rose 27 per cent on Monday.
POPULAR POSTS
Earthquakes and emissions undermine the idea of carbon storage in Texas
December 17, 2024
Rescuers search for cyclone survivors in devastated Mayotte
December 17, 2024
“Gilmore Girls” airs for a second season on Hulu
December 17, 2024
LIVE STREAM